Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
- DOI
- 10.1007/s12282-026-01889-6
- Published
- 2026-07-06
- Container
- Breast Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12282-026-01889-6,
title = {Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer},
author = {Kazutaka Narui and Kana Miyahara and Yukari Uemura and Akimitsu Yamada and Kazuhiro Araki and Fumie Fujisawa and Takahiro Nakayama and Takashi Ishikawa and Hirohito Seki and Kimito Yamada and Masahiro Kitada and Takayuki Iwamoto and Naruto Taira and Yuichiro Kikawa and Tomohiko Aihara and Hirofumi Mukai},
year = {2026},
journal = {Breast Cancer},
doi = {10.1007/s12282-026-01889-6},
url = {https://doi.org/10.1007/s12282-026-01889-6}
}RIS
TY - JOUR TI - Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer AU - Kazutaka Narui AU - Kana Miyahara AU - Yukari Uemura AU - Akimitsu Yamada AU - Kazuhiro Araki AU - Fumie Fujisawa AU - Takahiro Nakayama AU - Takashi Ishikawa AU - Hirohito Seki AU - Kimito Yamada AU - Masahiro Kitada AU - Takayuki Iwamoto AU - Naruto Taira AU - Yuichiro Kikawa AU - Tomohiko Aihara AU - Hirofumi Mukai PY - 2026 JO - Breast Cancer DO - 10.1007/s12282-026-01889-6 UR - https://doi.org/10.1007/s12282-026-01889-6 ER -
APA
Narui, K., Miyahara, K., Uemura, Y., Yamada, A., Araki, K., Fujisawa, F., Nakayama, T., Ishikawa, T., Seki, H., Yamada, K., Kitada, M., Iwamoto, T., Taira, N., Kikawa, Y., Aihara, T., & Mukai, H. (2026). Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer. Breast Cancer. https://doi.org/10.1007/s12282-026-01889-6
Source records
- crossref · retrieved 2026-09-25T06:43:15.474Z